Soluble Engineered Monomeric FC
France
13713301.3
Filed on 2013-03-14
13713301.3
Filed on 2013-03-14
Soluble Engineered Monomeric FC
Germany
13713301.3
Filed on 2013-03-14
13713301.3
Filed on 2013-03-14
METHODS FOR INDENTIFYING, DIAGNOSING, AND PREDICTING SURVIVAL OF LYMPHOMAS
US Patent 10,697,975
Filed on 2017-06-22
Filed on 2017-06-22
IL-15/IL-15 RECEPTOR ALPHA TREATMENT REGIMENS AND USE WITH THERAPEUTIC VACCINES
Patent Cooperation Treaty
PCT/US2017/042002
Filed on 2017-07-13
PCT/US2017/042002
Filed on 2017-07-13
FUROQUINOLINEDIONES AS INHIBITORS OF TDP2
US Patent 10,906,914
Filed on 2017-07-10
Filed on 2017-07-10
Furoquinolinedione As Inhibitors Of TDP2
European Patent
16703001.4
Filed on 2016-01-08
16703001.4
Filed on 2016-01-08
Furoquinolinedione As Inhibitors Of TDP2
Canada
2973484
Filed on 2016-01-08
2973484
Filed on 2016-01-08
Furoquinolinedione As Inhibitors Of TDP2
Australia
2016205137
Filed on 2016-01-08
2016205137
Filed on 2016-01-08
T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage
Australia
2017204103
Filed on 2017-06-16
2017204103
Filed on 2017-06-16
Expression Vectors Able To Elicit Improved Immune Response and Methods of Using Same
US Application 15/489,130
Filed on 2017-04-17
Filed on 2017-04-17